Avita Medical Inc. logo

Avita Medical Inc.

RCEL | NASDAQ
Chart Builder DCF Calculator
$11.66
+$0.82 (+7.56%)
Sep 22, 2026, 11:54 AM ET · Market open

Market Data

Market Cap
$269.3M
Enterprise Value
$259.98M
Beta
2.02
Average Volume
400.59K
Shares Outstanding (Diluted)
30.75M
Shares Change YoY
16.62%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US05380C1027

Price Performance

Price Change 1M
7.4%
Price Change 3M
176.5%
Price Change 6M
171.7%
Price Change YTD
212.4%
Price Change 1Y
83.1%
Price Change 3Y
-22.4%
Price Change 5Y
-40.5%
1M CAGR (ann.)
39.5%
1Y CAGR (ann.)
95.7%
5Y CAGR (ann.)
-10.5%
All-Time CAGR
-5.7%

Valuation

PE Ratio
-0.30
Forward PE
28.83
PEG Ratio
-0.23
Forward PEG
0.13
PS Ratio
3.56
Forward PS
2.40
PB Ratio
-9.67
P/FCF Ratio
-7.99
P/Adj. FCF Ratio
-6.41
P/OCF Ratio
-13.72
EV/Sales
3.44
EV/EBIT
-6.90
EV/EBITDA
-7.27
EV/FCF
-7.72
Earnings Yield
-330.5%
FCF Yield
-12.5%
Adj. FCF Yield
-15.6%

Financial Health

Net Cash
$9.31M
Total Debt
$1.82M
Cash & Short-Term Investments
$11.14M
Total Assets
$47.78M
Current Ratio
0.41
Quick Ratio
0.34
Debt / Equity Ratio
-1.74
Debt / EBITDA
-0.05
Debt / FCF
-0.05
OCF / Debt
-18.82
Interest Coverage
-6.52
Altman Z-Score
-12.40
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
81.6%
Operating Profit Margin
-46.6%
EBITDA Margin
-45.5%
Net Profit Margin
-57.0%
FCF Margin
-44.5%
Adj. FCF Margin
-55.6%
SBC / Revenue
9.6%
SBC Impact (per share)
-24.8%

Returns

Return on Assets
-90.2%
Return on Equity
231.9%
Return on Invested Capital
-136.9%
Return on Capital Employed
168.2%
Return on Tangible Assets
-101.3%

Historical Growth (CAGR)

Revenue CAGR 3Y
22.8%
Revenue CAGR 5Y
20.9%
Revenue CAGR 10Y
54.1%
EPS CAGR 3Y
-127.8%
EPS CAGR 5Y
-83.0%
EPS CAGR 10Y
-35.5%
FCF CAGR 3Y
27.5%
FCF CAGR 5Y
-13.1%
FCF CAGR 10Y
-13.4%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
8
EPS Growth Next 3Y
35.9%
Revenue Growth Next 3Y
75.9%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$0.24
EPS Growth Est (next Q)
-47.9%
Revenue Est (next Q)
$22.35M
Revenue Growth Est (next Q)
31.0%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$11
Price Target Upside
1.5%

Cash Flow

Operating Cash Flow
$-34.3M
Free Cash Flow
$-33.69M
Adj. Free Cash Flow
$-42.03M
FCF Per Share
-$0.77
OCF Per Share
-$0.79
OCF/S Ratio
-32.0%

Income Statement

Revenue
$75.63M
Gross Profit
$61.68M
Operating Income
$-35.22M
EBITDA
$-35.78M
Net Income
$-43.08M
EPS (Diluted)
-$35.83
Revenue / Employee
$334.65K
Profit / Employee
$-190.63K
Employees
226

© 2026 bestshares.com. All rights reserved.